methylprednisolone aceponate has been researched along with Atrophy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asadullah, K; Döcke, WD; Merbold, U; Mirshahpanah, P; Röse, L; Schäcke, H; Zollner, TM | 1 |
Jahn, P; Kecskés, A; Lange, L | 1 |
1 trial(s) available for methylprednisolone aceponate and Atrophy
Article | Year |
---|---|
Local tolerability of topically applied methylprednisolone aceponate.
Topics: Administration, Cutaneous; Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents; Atrophy; Betamethasone Valerate; Clobetasol; Dermatitis, Phototoxic; Double-Blind Method; Drug Tolerance; Female; Humans; Irritants; Male; Methylprednisolone; Occlusive Dressings; Ointments; Prednisolone; Skin; Skin Tests | 1993 |
1 other study(ies) available for methylprednisolone aceponate and Atrophy
Article | Year |
---|---|
Superior nuclear receptor selectivity and therapeutic index of methylprednisolone aceponate versus mometasone furoate.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Atrophy; Disease Models, Animal; Methylprednisolone; Mometasone Furoate; Pregnadienediols; Protein Binding; Rats; Rats, Mutant Strains; Rats, Nude; Rats, Wistar; Receptors, Androgen; Receptors, Cytoplasmic and Nuclear; Receptors, Mineralocorticoid; Receptors, Progesterone; Skin; Telangiectasis | 2007 |